Citation Information :
Ghosh S, Mukhopadhyay M, Namhata A, Chatterjee N. A Spectrum of Causative Organisms of Healthcare-associated Infections in a Tertiary Care Hospital of West Bengal: An Observational Study. Bengal Physician Journal 2020; 7 (1):2-7.
Background: Nosocomial infections are the foremost reasons for morbidity and mortality among hospitalized patients. Rampant use of antibiotics in infections has led to the emergence of multiresistant bacteria worldwide. Periodical review of sensitivity profiles is of utmost importance for optimal patient benefit. Aims and objectives: To explore the spectrum of organisms responsible for intensive care unit (ICU) and inpatient hospital-acquired sepsis and evaluate the pattern of antibiotic sensitivity of the organisms. Materials and methods: Samples were collected from all consecutive patients getting fever and satisfying the criteria for a nosocomial infection indoor as well as ICU, irrespective of etiology. They included sputum, blood, urine, and wound swabs. All samples were sent for a routine examination as well as a culture and sensitivity test. Descriptive statistical methods were used with the help of SPSS version 21. Results: The most frequent organisms for nosocomial infections in the ICU were Enterobacteriaceae (45%), Acinetobacter (13.7%), and Staphylococcus aureus (12.3%). In the general wards, the most common isolates were Enterobacteriaceae (59.9%), S. aureus (14.5%), Enterococcus (9.8%), and Pseudomonas (9.3%). There was a high percentage of extended-spectrum beta-lactamase among the Enterobacteriacae, methicillin-resistant S. aureus, and borderline oxacillin-resistant S. aureus among S. aureus and metallo-β-lactamase among the Acinetobacter and Pseudomonas. These indicate resistance to most beta-lactams, cephalosporins, and at times to carbapenems. There was also coresistance to fluoroquinolones and aminoglycosides. Conclusion: An antibiotic policy should be improvised for each healthcare facility on the basis of that point of time.
Nosocomial infections: epidemiology, prevention, control and surveillance. Asian Pac J Trop Biomed 2017;7(5): 478-482. DOI: 10.1016/j.apjtb.2017.01.019.
Prevalence of health care associated infections in a tertiary care hospital in Dakshina Kannada, Karnataka: a hospital based cross sectional study. Int J Med Res Health Sci 2015;4(2): 317–321.DOI: 10.5958/2319-5886.2015.00059.4.
Impact of inappropriate empirical antibiotic therapy on outcome of bacteremic adults visiting the ED. Am J Emerg Med 2012;30(8): 1447–1456.DOI: 10.1016/j.ajem.2011.11.010.
Hospital epidemiology and infection control in acute-care settings. Clin Microbiol Rev 2011;24(1): 141–173.DOI: 10.1128/CMR.00027-10.
Prevention of healthcare-associated infections: protecting patients, saving lives. Int J Commun Med Publ Health 2014;1(1): 67–68.DOI: 10.5455/2394-6040.ijcmph20141114.
Nosocomial infections and their control strategies. Asian Pac J Trop Biomed 2015;5(7): 509–514.DOI: 10.1016/j.apjtb.2017.01.019
Incidence of class A extended-spectrum beta-lactamases in Champagne-Ardenne (France): a 1 year prospective study. J Antimicrob Chemother 2007;60(5): 956–964. DOI: 10.1093/jac/dkm319.
Infection control in the ICU. Chest 2001;120(6): 2059–2093.DOI: 10.1378/chest.120.6.2059.
Relative prevalence of methicilline resistant Staphylococcus aureus and its susceptibility pattern in Mulago Hospital, Kampala, Uganda. Tanzan J Health Res. 2009;11(3): 149–153.DOI: 10.4314/thrb.v11i3.47703.
Community-associated MRSA–resistance and virulence converge. N Engl J Med 2005;352(14): 1485–1487.DOI: 10.1056/NEJMe058023.
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005–2006. Antimicrob Agents Chemother 2008;52(4): 1430–1437.DOI: 10.1128/AAC.01538-07.
ESBL, MBL and Ampc ß lactamases producing superbugs - Havoc in the intensive care units of Punjab India. J Clin Diagnostic Res 2013;7(1): 70–73.DOI: 10.7860/JCDR/2012/5016.2673.
The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, Enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med 2002;136(11): 834–844.DOI: 10.7326/0003-4819-136-11-200206040-00013.
Health-care-associated infection in Africa: a systematic review. Bull World Health Org. 2011;89:757–765. DOI: 10.2471/BLT.11.088179.
Nosocomial infections and associated risk factors in geriatric patients in the intensive care unit. Eurasian J Emerg Med 2016;15:177–180. DOI: 10.5152/eajem.2016.35744.
Incidence and risk factors of nazocomial infections in elderly and adult patients in intensive care units. Turk J Geriatr 2013;16:155–160. DOI: 10.5799/ahinjs.02.2015.01.0174.
Preventing hospital-acquired infections in low-income and middle-income countries: impact, gaps, and opportunities. Infect Dis Clin North Am 2016;30(3): 805–818.DOI: 10.1016/j.idc.2016.04.006.
Limiting the attributable mortality of nosocomial infection and multidrug resistance in intensive care units. Clin Microbiol Infect 2008;14(1): 5–13.DOI: 10.1111/j.1469-0691.2007.01835.x.
Role of hand hygiene in healthcare-associated infection prevention. J Hosp Infect 2009;73(4): 305–315.DOI: 10.1016/j.jhin.2009.04.019.
Infection control and changing health-care delivery systems. Emerg Infect Dis 2001;7(2): 170–173.DOI: 10.3201/eid0702.010202.
The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol 1985;121(2): 182–205.DOI: 10.1093/oxfordjournals.aje.a113990.